English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

IP-Based Incentives Against Antimicrobial Crisis: A European Perspective

MPS-Authors
/persons/resource/persons79145

Batista,  Pedro Henrique D.
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons205270

Byrski,  Dennis
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons51216

Lamping,  Matthias
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons53776

Romandini,  Roberto
MPI for Innovation and Competition, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Batista, P. H. D., Byrski, D., Lamping, M., & Romandini, R. (2019). IP-Based Incentives Against Antimicrobial Crisis: A European Perspective. IIC - international review of intellectual property and competition law, 50(1), 30-76. doi:10.1007/s40319-018-00782-w.


Cite as: http://hdl.handle.net/21.11116/0000-0002-CB4D-4
Abstract
The field of antimicrobials is considered to be facing a crisis. Increasing microbial resistance is creating a demand for new drugs, which however is not being matched by privately funded R&D. The reasons for this market failure are of a technical and economic nature. The present article analyzes what changes to IP- based incentives are conceivable in the European Union (EU) in order to address the antimicrobial crisis. Since the assessment of the suitability of the analyzed options depends on interdisciplinary research, this article also proposes a research agenda to be considered for the implementation of public policies in this field.